✦ LIBER ✦

Phase I/II clinical trial using HLA-A24-restricted peptide vaccine derived from KIF20A for patients with advanced pancreatic cancer

✍ Scribed by Asahara, Shingo; Takeda, Kazuyoshi; Yamao, Kenji; Maguchi, Hiroyuki; Yamaue, Hiroki

Book ID: 121587914
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 786 KB
Volume: 11
Category: Article
ISSN: 1479-5876
DOI: 10.1186/1479-5876-11-291

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I Clinical Trial of Peptide Vaccin

Phase I Clinical Trial of Peptide Vaccination With KIF20A and VEGFR1 Epitope Peptide in Patients With Advanced Pancreatic Cancer

✍ Kato, Junko ;Nagahara, Akihito ;Kodani, Tomohiro ;Higashihara, Yoshie ;Inami, Ko 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Phase I clinical trial of survivin-deriv

Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer

✍ Akihiro Miyazaki; Junichi Kobayashi; Toshihiko Torigoe; Yoshihiko Hirohashi; Tak 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB

Clinical and Immunologic Responses of HL

Clinical and Immunologic Responses of HLA-A3+ Breast Cancer Patients Vaccinated with the HER2/neu-Derived Peptide Vaccine, E75, in a Phase I/II Clinical Trial

✍ Ritesh Patil; Guy T. Clifton; Jarrod P. Holmes; Asna Amin; Mark G. Carmichael; J 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 728 KB

Phase I clinical trial using peptide vac

Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer

✍ Motoki Miyazawa; Ryuji Ohsawa; Takuya Tsunoda; Seiko Hirono; Manabu Kawai; Masaj 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

Phase I clinical trial: T-cell therapy f

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

✍ Murphy, G.; Tjoa, B.; Ragde, H.; Kenny, G.; Boynton, A. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 791 KB

## BACKGROUND. Conventional treatment for metastatic prostate cancer have failed to demonstrate curative potential in all patients. Investigations involving the role of T-cell immunity in the clearance of neoplastic cells are now available. Development of T-cell immunotherapy may give a new approa